Hemostatic devices and methods of use
AssigneeTYRX, Inc.
InventorsSATISH PULAPURA, Fatima Buevich, Jorie S. Soskin, Franklin R. Mansfield, Kai R. Worrell, Charlie Wood, Jorge Alberto Trevino Blanco
Life of this patent
Estimating the term…
Abstract
An anchorage device is provided that is configured to surround an implantable medical device. The anchorage device includes a substrate formed from a first material and a second material. At least one of the first and second materials includes a hemostatic agent. Kits, systems and methods are disclosed.
Claims20
An anchorage device configured to surround an implantable medical device, the anchorage device comprising:
- a substrate formed from a first material and a second material, wherein at least one of the first and second materials comprises a hemostatic agent.
An anchorage device configured to surround an implantable medical device, the anchorage device comprising:
- a substrate formed from a first material and a second material, wherein at least one of the first and second materials comprises a hemostatic agent,
- wherein the first material comprises the hemostatic agent and the second material is free of any hemostatic agents, the second material comprising an active pharmaceutical ingredient.
An anchorage device configured to surround an implantable medical device, the anchorage device comprising:
- a substrate formed from a first material and a second material, wherein the first material comprises tranexamic acid and the second material is free of any hemostatic agents, the second material comprising rifampin and minocycline.
Dependencies are inferred from the claim text.